In case you missed it: Dec. 7 to Dec. 11
This week’s top articles included:
Reversing endometrial hyperplasia with levonorgestrel-intrauterine system: a Cochrane review
In the largest meta-analysis study to date, researchers find that a levonorgestrel-intrauterine system (LNG-IUS) used for 3 to 6 months is likely more effective than non‐intrauterine progestogens for reversing endometrial hyperplasia (EH).
A look back at 2020
What a year 2020 has been! We hope to look back on it and recognize it as an outlier or anomaly—hoping life will at some point return to normal.
Protocols for High-Risk Pregnancies, 7th Edition
Snapshot: Protocol 56 - Shoulder Dystocia
Managing fetal sex discordance in cfDNA
This article presents a clinical algorithm and four cases to consider.
Lymphangioma circumscriptum
Could you recognize this rare vulvar condition?
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
